| Revision as of 13:50, 20 October 2021 editOxinabox (talk | contribs)240 edits Add comment about US-Centric Anxiety sectionTag: Reverted← Previous edit |
Latest revision as of 14:30, 3 January 2025 edit undoLowercase sigmabot III (talk | contribs)Bots, Template editors2,305,076 editsm Archiving 1 discussion(s) to Talk:Beta blocker/Archive 1) (bot |
| (7 intermediate revisions by 5 users not shown) |
| Line 1: |
Line 1: |
|
⚫ |
{{Talk header}} |
|
{{dashboard.wikiedu.org assignment | course = Misplaced Pages:Wiki_Ed/University_of_Hawaii/JABSOM_MS1_Wikipedia_Editing_2019_(Fall) | assignments = ], ], ], ], ] | start_date = 2019-07-23 | end_date = 2019-08-30 }} |
|
|
⚫ |
{{WikiProject banner shell|class=C| |
|
|
|
|
|
{{WikiProject Pharmacology|importance=top}} |
|
|
}} |
|
⚫ |
{{Reliable sources for medical articles}} |
|
{{User:MiszaBot/config |
|
{{User:MiszaBot/config |
|
|archiveheader = {{aan}} |
|
|archiveheader = {{aan}} |
| Line 10: |
Line 13: |
|
|archive = Talk:Beta blocker/Archive %(counter)d |
|
|archive = Talk:Beta blocker/Archive %(counter)d |
|
}} |
|
}} |
| ⚫ |
{{Reliable sources for medical articles}} |
|
| ⚫ |
{{talk header}} |
|
| ⚫ |
{{WikiProject Pharmacology|class=C|importance=top}} |
|
|
{{Connected contributor (paid)|User1=Cglife.trummler|U1-employer=CG Life|U1-client=Impact Journals}}. |
|
{{Connected contributor (paid)|User1=Cglife.trummler|U1-employer=CG Life|U1-client=Impact Journals}}. |
|
|
|
|
== Hyperthyroidism == |
|
|
|
|
|
I removed hyperthyroidism from the list of contraindications because the source doesn't list it as a contraindication for beta blockers; it says that it can exacerbate hyperthyroid symptoms if discontinued abruptly. Hyperthyroidism is also listed as an ''indication'' for beta blockers earlier in the article, so it's contradicting itself. |
|
|
|
|
|
I also removed the sentence claiming that beta blockers should be used with caution because "tachycardia is a useful monitoring parameter in thyroid disease" because it was uncited and I doubt it's possible to find a citation for this. I'm not sure what kind of doctor would be ok with not treating a patient's abnormally high heart rate because it's a (not very precise) indicator that their thyroid levels are abnormal. |
|
|
|
|
|
I left the line about abrupt withdrawal possibly causing a thyroid storm because that is in the propanolol document (and added the citation that wasn't there), but it doesn't contraindicate the use of beta blockers to treat hyperthyroidism and shouldn't be in that section. I'm just not sure how to fit it into the Adverse Effects section smoothly. I'm also not sure if it should even be included in the article, since I assume hyperthyroidism is not the only condition for which suddenly stopping beta blockers can be potentially dangerous, but it's the only disorder for which it's mentioned. (And if we're being pedantic, that citation is only for propanolol and not for other beta blockers.) |
|
|
|
|
|
|
|
|
== Anxiety section US-Centric == |
|
|
Right now the Anxiety section starts with "Officially, beta blockers are not approved for anxiolytic use by the U.S. Food and Drug Administration." |
|
|
and doesn't have much more content than that. |
|
|
However, in many other countries, e.g. , , they are occasionally used for this. |
|
|
At present, I don't have time to format that into a update to that paragraph. |
|
|
] (]) 13:50, 20 October 2021 (UTC) |
|
.
